◂ Announcements

Dec 16, 2021ACQUISITIONUnited States

Allergan Aesthetics completes acquisition of Soliton

Allergan Aesthetics, an AbbVie company, completed its acquisition of Soliton, Inc., adding the RESONIC device for cellulite treatment to its body contouring portfolio.

Status

Completed

ProductsRESONIC device for cellulite treatmenttattoo removal device

CompaniesAbbVie investor Allergan Aesthetics acquirer Soliton target

Sectors#Medical Devices

“Allergan Aesthetics, an AbbVie company, today announced the successful completion of its acquisition of Soliton, Inc.”prnewswire.com

1 source
prnewswire.comAllergan Aesthetics Completes Acquisition of SolitonAbbVieDec 16, 2021

Summarized from public sources; check the original articles before acting on it.

More from AbbVie

profile ▸

Jan 25, 2024EXPANSIONTuas Biomedical Park, Singapore, Singapore$223.0M100 jobsops 2026
AbbVie expands biologics manufacturing capacity in Singapore with $223M investment
AbbVie news.abbvie.com
Oct 30, 2023CONTRACTUnited States
NEXGEL subsidiary signs supply agreement with AbbVie for gel pads
NEXGEL AbbVie customer globenewswire.com
Sep 20, 2022PARTNERSHIP$60.0M
iSTAR Medical and AbbVie enter strategic alliance for MINIject device
iSTAR Medical AbbVie partner private-equitynews.com
Jul 20, 2022PARTNERSHIP$60.0M
AbbVie and iSTAR Medical form strategic alliance for glaucoma treatment
AbbVie partner iSTAR Medical partner news.abbvie.com
Jan 16, 2018EXPANSIONBallytivnan, Sligo, Ireland$139.0M100 jobs
AbbVie expands oncology manufacturing facility in Sligo, Ireland
AbbVie gov.ie

Loading…

Allergan Aesthetics completes acquisition of Soliton · Endata